CIT AWARE: Evolving Paradigms in Cancer Immunotherapy:

Use of Biomarkers and Combination Therapy Targeting the PD-1/PD-L1 Pathway

These case-based enduring activities will cover the treatment and management of patients with advanced solid tumors who are treated or eligible for treatment with immunotherapy. These activities are designed to meet the educational needs of oncologists, oncology pharmacists, oncology nurses and other healthcare professional involved in the management of patients with advanced solid tumors who are treated or eligible for treatment with immunotherapy.